The following lists various projects in whlich MCI was completelly or partially responsible for obtaining FDA approval, either for marketing or for clinical investigation.
First non-thermal contact lens disinfecting solutions
Novel polymer dry eye solution
First commercially available punctum plug
Numerous contact lens studies: developmental and clinical investigations of hydrophilic soft and high DK RGP lenses
Lactoplate ( lactoferrin assaly of lacrimal fluid)
Sulfur hexaflluoride and perfluoropropane for treatment of retinal detachments
Initial clinical studies of silicone oil for retinal detachments
Initial formulations and submission for the use of cyclsporine and the treament of dry eye conditions
Clinical study of calcium carbonate ointment for the supracutaneous treatment of dry eyes
First tandem scanning confocal microscope for clinical use
Dye lasers for ophthalmic use
Clinical linvestigation of cultured corneal endothelial cells for DLEK procedures.
